Carondelet Health Network first in Tucson to use next-generation TAVR system to treat heart valve disease patients
Nov 2, 2022
Device improves quality of life for patients with debilitating heart valve disease who are prohibitive surgical risk
TUCSON (November 2, 2022) – Carondelet St. Mary’s Hospital is at the forefront of cardiac care in the United States by being the first in Tucson and Southern Arizona to offer the advanced technology of the newly redesigned Evolt FX TAVR System for patients with heart failure.
Symptomatic severe aortic stenosis (AS) is a common heart valve disease that occurs when the aortic valve narrows, restricting blood flow from the heart. This makes the heart work harder to pump blood to the rest of the body and ultimately impacts an individual’s daily activities. If left untreated, AS patients can die from heart failure in as little as two years, so it is important that patients have access to the latest technology and most advanced treatment options.
The heart care team in the cardiac cath lab at Carondelet St. Mary’s Hospital is the first in Southern Arizona to introduce the device as a treatment option for AS patients. The procedure was performed by Interventional Cardiologist Dr. Kapildeo Lotun, medical director of St. Mary’s Hospital’s Structural Heart Program.
“This is exciting technology for our community and it’s very significant that Carondelet St. Mary’s Hospital was chosen as the first hospital in Tucson to offer this TAVR procedure equipment to its patients,” said Dr. Kapildeo Lotun, interventional cardiologist and St. Mary’s Hospital’s Structural Heart Program medical director.
The device includes a redesigned flexible delivery system to allow for 360-degree freedom of motion for stable, predictable deployment. The FDA recently approved the technology, providing physicians another option to treat the growing AS patient population indicated for TAVR, a minimally invasive treatment alternative to open-heart surgery. The TAVR procedure involves guiding a catheter through a small incision in the groin, neck or space between the ribs to replace the function of the diseased aortic valve.
“This latest advancement is an exciting milestone that demonstrates Carondelet St. Mary’s commitment to improving cardiac care for heart valve disease patients,” said David Ziolkowski, Carondelet St. Mary’s Hospital chief executive officer.
Carondelet St. Mary’s Hospital is recognized for its cardiovascular care, including its modern and minimally invasive heart and vascular surgery. Its renowned Structural Heart Program highlight Carondelet Health Network’s commitment and success in ensuring their cardiovascular patients receive treatment that meets research-based guidelines based on the latest scientific evidence.
TUCSON (November 2, 2022) – Carondelet St. Mary’s Hospital is at the forefront of cardiac care in the United States by being the first in Tucson and Southern Arizona to offer the advanced technology of the newly redesigned Evolt FX TAVR System for patients with heart failure.
Symptomatic severe aortic stenosis (AS) is a common heart valve disease that occurs when the aortic valve narrows, restricting blood flow from the heart. This makes the heart work harder to pump blood to the rest of the body and ultimately impacts an individual’s daily activities. If left untreated, AS patients can die from heart failure in as little as two years, so it is important that patients have access to the latest technology and most advanced treatment options.
The heart care team in the cardiac cath lab at Carondelet St. Mary’s Hospital is the first in Southern Arizona to introduce the device as a treatment option for AS patients. The procedure was performed by Interventional Cardiologist Dr. Kapildeo Lotun, medical director of St. Mary’s Hospital’s Structural Heart Program.
“This is exciting technology for our community and it’s very significant that Carondelet St. Mary’s Hospital was chosen as the first hospital in Tucson to offer this TAVR procedure equipment to its patients,” said Dr. Kapildeo Lotun, interventional cardiologist and St. Mary’s Hospital’s Structural Heart Program medical director.
The device includes a redesigned flexible delivery system to allow for 360-degree freedom of motion for stable, predictable deployment. The FDA recently approved the technology, providing physicians another option to treat the growing AS patient population indicated for TAVR, a minimally invasive treatment alternative to open-heart surgery. The TAVR procedure involves guiding a catheter through a small incision in the groin, neck or space between the ribs to replace the function of the diseased aortic valve.
“This latest advancement is an exciting milestone that demonstrates Carondelet St. Mary’s commitment to improving cardiac care for heart valve disease patients,” said David Ziolkowski, Carondelet St. Mary’s Hospital chief executive officer.
Carondelet St. Mary’s Hospital is recognized for its cardiovascular care, including its modern and minimally invasive heart and vascular surgery. Its renowned Structural Heart Program highlight Carondelet Health Network’s commitment and success in ensuring their cardiovascular patients receive treatment that meets research-based guidelines based on the latest scientific evidence.
About Carondelet Health Network
Carondelet Health Network is comprised of Carondelet St. Mary’s Hospital, Carondelet St. Joseph’s Hospital, Carondelet Holy Cross Hospital, Carondelet Marana Hospital, Carondelet St. Raphael’s Emergency Center, Carondelet Neurological Institute, Carondelet Heart and Vascular Institute, as well as primary care and specialty physician offices. For more information visit www.carondelet.org.
